Hopeful scientific data: Vitamin C as a 'shield' against multiple organ failure
Translated from Greek, summarized and contextualized by DistantNews.
At a glance
Analysis
Documents & data
Context piece
- Intravenous high-dose vitamin C shows promise in reducing mortality and sepsis risk in trauma patients, according to a review in 'BMJ Military Health'.
- The review of six studies involving 5,171 patients indicated significant reductions in 30-day mortality and shorter hospital stays.
- While promising, researchers noted limitations including a small number of studies and variations in methodology, suggesting further research is needed.
Emerging scientific data suggests that high-dose intravenous vitamin C may act as a shield against multiple organ failure and sepsis in trauma patients. A review of scientific data published in the journal 'BMJ Military Health' indicates that this treatment could reduce the risk of death and shorten hospital stays.
The intravenous administration of vitamin C in high doses appears to reduce the risk of death and sepsis in trauma patients, while also contributing to shortening their hospitalization.
The research team analyzed databases of studies published up to the end of 2025, focusing on the effects of high-dose intravenous vitamin C. Their review specifically examined 30-day mortality rates, disease severity, the frequency of complications like sepsis and multiple organ failure, and the duration of hospitalization.
Out of 108 identified studies, only six met the inclusion criteria, collectively covering 5,171 patients. The results revealed a significant decrease in mortality within the first 30 days post-treatment. Patients receiving vitamin C also experienced considerably shorter stays in intensive care units and hospitals overall.
The results showed a significant reduction in mortality within the first 30 days and noticeably shorter stays both in intensive care units and in the hospital.
Furthermore, four of the six studies reported lower rates of sepsis among patients treated with vitamin C, while two studies found reduced instances of multiple organ failure. The researchers pointed out that variations between the studies suggest the treatment's effectiveness might depend on the specific clinical context and may not be universally applicable to all critical illness cases.
The researchers point out that the variations between the studies suggest that the effectiveness of the treatment may depend on the specific clinical context and may not be fully generalizable to all cases of critical illness.
Despite these promising findings, the researchers acknowledged significant limitations. These include the small number of available studies, the fact that half were observational, and differences in methodology, vitamin C dosages, concurrent therapies, and outcome recording. None of the studies examined intravenous vitamin C as a standalone treatment, making it difficult to isolate its specific impact. Nevertheless, the researchers emphasized that even small reductions in mortality, sepsis, multiple organ failure, or the need for intensive care could justify the use of intravenous vitamin C in trauma patients.
Even small reductions in mortality, sepsis, multiple organ failure, or the need for intensive care could justify the use of intravenous vitamin C in patients with trauma.
DistantNews Editorial
Originally published by Ta Nea in Greek. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.
More Stories
From Our Blog
What Gets Lost (and Found) When News Is Translated
The Critical Role of Diaspora Media in Global News
What Travellers Should Know About Countries with Restricted Press
A Digital Nomad's Guide to Following Local News
How the Same Story Looks Different in Different Countries
